Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial

Teoh, E, Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X et al. (15 more authors) (2017) Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial. In: International Journal of Radiation Oncology Biology Physics. 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), 24-27 Sep 2017, San Diego, CA, USA. Elsevier , pp. 1316-1317.

Abstract

Metadata

Authors/Creators:
  • Teoh, E
  • Bottomley, D
  • Scarsbrook, A ORCID logo https://orcid.org/0000-0002-4243-032X
  • Payne, H
  • Afaq, A
  • Bomanji, J
  • Van As, N
  • Chua, S
  • Hoskin, P
  • Chambers, A
  • Cook, GJ
  • Warbey, VS
  • Chau, A
  • Ward, P
  • Miller, MP
  • Stevens, DJ
  • Wilson, L
  • Gleeson, FV
Dates:
  • Accepted: 1 September 2017
  • Published (online): 15 November 2017
  • Published: 1 December 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 02 Jan 2018 13:29
Last Modified: 02 Jan 2018 13:29
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ijrobp.2017.09.015
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)